COTA Research Recognized at ASH 2025: Advancing Real-World Evidence in Hematologic Malignancies
COTA’s scientific contributions have once again been recognized by the American Society of Hematology (ASH) Annual Meeting and Exposition, one of the most prestigious global forums for advancing hematology research. This year, five studies using COTA’s real-world data (RWD) and coauthored by our research team were accepted for presentation—including COTA’s first-ever oral presentation at ASH. […]
COTA Names C.K. Wang, MD as Chief Executive Officer, Reinforcing Its Commitment to Trusted, High-Quality Oncology Data and Services
Medical oncologist and real-world data leader succeeds Miruna Sasu, whose leadership expanded COTA’s impact across life sciences. A Leader Rooted in Both Medicine and Data COTA, an oncology real-world data and analytics company, today announced that C.K. Wang, MD has been appointed Chief Executive Officer, effective immediately. Dr. Wang has served as COTA’s Chief Medical […]
Extending COTA’s global reach with RWD in oncology research
Cancer is a disease that respects no borders: it affects everyone around the world, no matter where they live. The universal nature of cancer makes it even more important for international partners to collaborate on research and share learnings to improve outcomes everywhere, from the Americas to Europe, Africa to Asia, and beyond. This year, […]
3 key takeaways from ASCO 2025: Staying nimble in a changing environment
3 key takeaways from ASCO 2025: Staying nimble in a changing environment The annual meeting of the American Society of Clinical Oncology (ASCO) is a chance for oncology professionals, patient advocates, data experts, and industry representatives to come together and share the latest research in cancer care. This year, thousands of attendees descended on Chicago […]
Minimizing “missingness” in cancer mortality statistics with real-world data
How real-world data can tell the story of breast, ovarian and uterine cancers at a pivotal moment in women’s health Nearly 4 million women worldwide are diagnosed with breast or gynecological cancers each year. Yet too many factors around these diseases are still poorly understood, including why there are so many disparities and variances in […]
How real-world data can tell the story of breast, ovarian and uterine cancers at a pivotal moment in women’s health
Nearly 4 million women worldwide are diagnosed with breast or gynecological cancers each year. Yet too many factors around these diseases are still poorly understood, including why there are so many disparities and variances in treatment and outcomes. Clinical trials have been helpful in illuminating some of these issues. And early approaches to leveraging real-world […]
Expanding insights into cancer with real-world data on solid tumors
Cancer comes in many forms, including hematologic malignancies that originate in blood-forming tissues or in the cells of the immune system, and solid tumors that form as abnormal masses of tissue and are named for the type of cells and classified by the organ or biologic structure from which they originate. Hematologic cancers, such as […]
Sustainability spotlight: How COTA is approaching corporate ecological responsibility
Since the turn of the century, there’s been a growing recognition that the health of our friends, families, & communities is intimately tied to the health of our physical environment. Safe water, clean air, & a diverse, balanced ecosystem are essential conditions for life to thrive & innovation to flourish.As a company focused on healthcare […]
Using AI to transform life sciences data analysis
Using AI to transform life sciences data analysis: An early look at CAILIN’s performance COTA has launched the COTA AI Language Insights Network (CAILIN) to expedite data analytics. CAILIN is an oncology trained, on-demand insight generator designed to answer a variety of fundamental questions pertaining to data analytics, including specific cohort size, subgroup breakdowns, […]
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
NEW YORK–(BUSINESS WIRE)–COTA Inc., a leader in real-world data (RWD) and analytics for oncology, announces a new partnership with leading precision oncology company Guardant Health Inc. (Nasdaq: GH) that will allow biopharmaceutical researchers to access the combined resources of COTA’s research-grade electronic health record (EHR) data from academic and community care centers and Guardant’s clinicogenomic […]